Jagsonpal Pharmaceuticals Limited (BOM:507789)

Jagsonpal Pharmaceuticals Statistics

Total Valuation

BOM:507789 has a market cap or net worth of INR 14.09 billion. The enterprise value is 12.59 billion.

Market Cap	14.09B
Enterprise Value	12.59B

Important Dates

The last earnings date was Monday, October 27, 2025.

Earnings Date	Oct 27, 2025
Ex-Dividend Date	Sep 12, 2025

Share Statistics

Current Share Class	66.72M
Shares Outstanding	n/a
Shares Change (YoY)	+0.41%
Shares Change (QoQ)	-1.58%
Owned by Insiders (%)	11.78%
Owned by Institutions (%)	1.45%
Float	15.87M

Valuation Ratios

The trailing PE ratio is 22.75.

PE Ratio	22.75
Forward PE	n/a
PS Ratio	4.99
PB Ratio	5.57
P/TBV Ratio	8.24
P/FCF Ratio	35.17
P/OCF Ratio	34.98
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 22.81, with an EV/FCF ratio of 31.42.

EV / Earnings	20.32
EV / Sales	4.45
EV / EBITDA	22.81
EV / EBIT	27.52
EV / FCF	31.42

Financial Position

The company has a current ratio of 6.07, with a Debt / Equity ratio of 0.03.

Current Ratio	6.07
Quick Ratio	5.46
Debt / Equity	0.03
Debt / EBITDA	0.16
Debt / FCF	0.22
Interest Coverage	49.02

Financial Efficiency

Return on equity (ROE) is 27.53% and return on invested capital (ROIC) is 12.20%.

Return on Equity (ROE)	27.53%
Return on Assets (ROA)	10.26%
Return on Invested Capital (ROIC)	12.20%
Return on Capital Employed (ROCE)	17.21%
Revenue Per Employee	2.02M
Profits Per Employee	442,759
Employee Count	1,399
Asset Turnover	1.01
Inventory Turnover	6.31

Taxes

In the past 12 months, BOM:507789 has paid 166.79 million in taxes.

Income Tax	166.79M
Effective Tax Rate	21.21%

Stock Price Statistics

The stock price has decreased by -1.28% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-1.28%
50-Day Moving Average	224.83
200-Day Moving Average	230.50
Relative Strength Index (RSI)	41.27
Average Volume (20 Days)	4,248

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BOM:507789 had revenue of INR 2.83 billion and earned 619.42 million in profits. Earnings per share was 9.18.

Revenue	2.83B
Gross Profit	1.80B
Operating Income	457.38M
Pretax Income	786.21M
Net Income	619.42M
EBITDA	537.55M
EBIT	457.38M
Earnings Per Share (EPS)	9.18

Balance Sheet

The company has 1.59 billion in cash and 88.36 million in debt, giving a net cash position of 1.50 billion.

Cash & Cash Equivalents	1.59B
Total Debt	88.36M
Net Cash	1.50B
Net Cash Per Share	n/a
Equity (Book Value)	2.53B
Book Value Per Share	37.80
Working Capital	1.69B

Cash Flow

In the last 12 months, operating cash flow was 402.85 million and capital expenditures -2.16 million, giving a free cash flow of 400.69 million.

Operating Cash Flow	402.85M
Capital Expenditures	-2.16M
Free Cash Flow	400.69M
FCF Per Share	n/a

Margins

Gross margin is 63.59%, with operating and profit margins of 16.18% and 21.91%.

Gross Margin	63.59%
Operating Margin	16.18%
Pretax Margin	27.81%
Profit Margin	21.91%
EBITDA Margin	19.02%
EBIT Margin	16.18%
FCF Margin	14.18%

Dividends & Yields

This stock pays an annual dividend of 2.50, which amounts to a dividend yield of 1.19%.

Dividend Per Share	2.50
Dividend Yield	1.19%
Dividend Growth (YoY)	25.00%
Years of Dividend Growth	n/a
Payout Ratio	26.89%
Buyback Yield	-0.41%
Shareholder Yield	0.78%
Earnings Yield	4.40%
FCF Yield	2.84%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on January 8, 2025. It was a forward split with a ratio of 2.5.

Last Split Date	Jan 8, 2025
Split Type	Forward
Split Ratio	2.5

Scores

Altman Z-Score	n/a
Piotroski F-Score	6